TNFAIP3 and B-cell non-Hodgkin lymphoma: A20 is frequently inactivated by somatic mutations and/or deletions in different subtypes of B-cell non-Hodgkin lymphomas, Hodgkin’s lymphoma, and T-cell malignancy-Sézary syndrome (SS).